US 12187744
IRAK4 degraders and synthesis thereof
granted A61KA61K31/519A61P
Quick answer
US patent 12187744 (IRAK4 degraders and synthesis thereof) held by Kymera Therapeutics, Inc. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/519, A61P, A61P29/00